Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Telo Genomics Corp TDSGF


Primary Symbol: V.TELO

Healthcare Industrials Biotechnology Conglomerates
Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display... see more

Recent & Breaking News (TSXV:TELO)

IIROC Trading Halt - NVO and DXD

Canada NewsWire May 31, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

GlobeNewswire May 10, 2018

3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma

GlobeNewswire April 3, 2018

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

GlobeNewswire March 28, 2018

3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer

GlobeNewswire March 6, 2018

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

GlobeNewswire March 1, 2018

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

GlobeNewswire February 20, 2018

3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement

GlobeNewswire December 5, 2017

3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results

GlobeNewswire December 1, 2017

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

GlobeNewswire November 29, 2017

3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement

GlobeNewswire November 27, 2017

3D Signatures Inc. Announces Brokered Private Placement

MarketWire Canada October 25, 2017

3D Signatures Reports Financial Results for 2017

GlobeNewswire October 24, 2017

3D Signatures Announces Changes to Its Board of Directors and Audit Committee

GlobeNewswire October 19, 2017

3D Signatures Announces Completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

GlobeNewswire October 10, 2017

3D Signatures Announces Change to Its Board of Directors

GlobeNewswire October 10, 2017

3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update

GlobeNewswire October 4, 2017

3D Signatures Announces Private Placement With Strategic Partner and Prospectus Update

GlobeNewswire October 3, 2017

3D Signatures Announces Change to Its Board of Directors

GlobeNewswire August 11, 2017

3D Signatures Inc. Announces Short Form Prospectus Offering to Raise Up to C$5 Million

MarketWire Canada July 19, 2017